These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
204 related articles for article (PubMed ID: 17542093)
1. Stop TB Partnership has provided treatments for 10 million people in 6 years. Wkly Epidemiol Rec; 2007 Jun; 82(22/23):206-7. PubMed ID: 17542093 [No Abstract] [Full Text] [Related]
2. Tuberculosis control goals unlikely to be met by 2005. Sharma DC Lancet; 2004 Apr; 363(9415):1122. PubMed ID: 15068013 [No Abstract] [Full Text] [Related]
3. The worldwide epidemic of multidrug-resistant tuberculosis. The Lancet Infectious Diseases Lancet Infect Dis; 2011 May; 11(5):333. PubMed ID: 21530885 [No Abstract] [Full Text] [Related]
4. Control of tuberculosis in India. Mohapatra PR Lancet; 2003 Oct; 362(9391):1243. PubMed ID: 14568763 [No Abstract] [Full Text] [Related]
5. Epidemiology, control and treatment of multidrug-resistant tuberculosis. Chaulet P; Raviglione M; Bustreo F Drugs; 1996; 52 Suppl 2():103-7; discussion 107-8. PubMed ID: 8869846 [No Abstract] [Full Text] [Related]
6. Essential components of a tuberculosis control program within Australia. National Tuberculosis Advisory Committee Commun Dis Intell Q Rep; 2014 Dec; 38(4):E397-400. PubMed ID: 25631607 [No Abstract] [Full Text] [Related]
7. Drug resistant tuberculosis: back to sanatoria, surgery and cod-liver oil? Veen J Eur Respir J; 1995 Jul; 8(7):1073-5. PubMed ID: 7589389 [No Abstract] [Full Text] [Related]
8. World Health Organization fact sheet. Tuberculosis. World Health Organization Saudi Med J; 2004 Aug; 25(8):1136-8. PubMed ID: 15457607 [No Abstract] [Full Text] [Related]
9. Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultation. Migliori GB; Lienhardt C; Weyer K; van der Werf MJ; Blasi F; Raviglione MC Eur Respir J; 2014 Dec; 44(6):1412-7. PubMed ID: 25435528 [No Abstract] [Full Text] [Related]
10. New technologies for tuberculosis control: the Stop TB Partnership's Task Force on Retooling. Wkly Epidemiol Rec; 2007 Apr; 82(15):130-2. PubMed ID: 17432439 [No Abstract] [Full Text] [Related]
11. DOTS and drug resistance: a silver lining to a darkening cloud. Chaisson RE; Coberly JS; De Cock KM Int J Tuberc Lung Dis; 1999 Jan; 3(1):1-3. PubMed ID: 10094162 [No Abstract] [Full Text] [Related]